Risk factors for complications following lung resection for bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 633s Year: 2005
Nd:YAG laser resection in the palliative treatment of centrally located lung cancer Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007
Risk factors for cardiac complications after lung cancer surgery Source: Eur Respir J 2004; 24: Suppl. 48, 172s Year: 2004
Risk quantification for postoperative pulmonary complications after pulmonary resection in lung cancer patients Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008
Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Nd:YAG laser resection vs. Nd:YAG laser resection combined with brachytherapy and external beam radiotherapy in the treatment of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 596s Year: 2006
Impact of chronic obstructive pulmonary disease on the recurrence and second tumors of lung cancer after surgical resection Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019
Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD Source: International Congress 2016 – COPD diagnosis and management Year: 2016
Cumulative incidence and associated risk factor of chronic pulmonary infection after lung resection surgery for lung cancer Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
Relationship between COPD and complications rate after lung cancer surgery Source: Eur Respir J 2005; 26: Suppl. 49, 173s Year: 2005
Airway complications after lung transplantation: risk factors and survival Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020
Is the COPD-index a significant prognostic factor of functional results of lobectomy in COPD patients? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007
Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018
Lung resections for peripheral lung lesions in patients with severe COPD Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007
Endoscopic management of early lung cancer: HFEC, cryo, brachy, PDT, YAG; the pulmonologist’s view Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated? Year: 2005
Nd:YAG laser surgery for tumours of the cervical trachea Source: Eur Respir J 2002; 20: Suppl. 38, 616s Year: 2002
Associations of efficacy outcomes following bronchoscopic thermal vapor ablation (BTVA) for the treatment of heterogeneous emphysema Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011